Skip to content

Moderna in talks to supply 40M doses of COVID-19 vaccine to Japan

August 28, 2020

Moderna (NASDAQ:MRNA) confirms that it is in discussions with Japan’s Ministry of Health, Labor and Welfare for the potential purchase of 40M or more doses of COVID-19 vaccine mRNA-1273.

Under the terms of the proposed agreement, it will supply the product and Takeda Pharmaceutical Co., Ltd. (NYSE:TAK) will distribute beginning in H1 2021, if the vaccine is approved.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: